Advil Liquigels

Product NDC
67751-148
Requested package NDC
67751-148-01
11-digit product format
677510148
Labeler code
67751
Product ID
67751-148_ebe15362-ec80-baba-e053-2995a90a112e
Type
HUMAN OTC DRUG
Nonproprietary name
IBUPROFEN
Dosage form
CAPSULE, LIQUID FILLED
Route
ORAL
Labeler
Navajo Manufacturing Company Inc.
Application
NDA020402
Marketing category
NDA
Marketing start
2016-09-20
Substance
IBUPROFEN
Active strength
200 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage67751-14867751-148-01DDiscontinued by firm2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source dateSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-312ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-100efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09557ba5c1ecfa…9c80585c8c6e…

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N020402-001ADVIL LIQUI-GELSIBUPROFENEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-20
N020402-002ADVIL MIGRAINE LIQUI-GELSIBUPROFENEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-16

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-20011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-16011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-2031067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-1631067a03dcf5…
2025-08-23 18:47 UTC2025-08N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-206a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-166a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-20fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-16fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-20b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-16b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-2003ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-1603ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-202680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-162680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-205bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-165bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-20d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-16d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-20d06236e962d9…
2024-10-29 15:01 UTC2024-10N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-16d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-2079d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-1679d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-20301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-16301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-201e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-161e350fbaab3a…
2024-05-31 18:47 UTC2024-05N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-208072bd15b7f6…
2024-05-31 18:47 UTC2024-05N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-168072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-205c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-165c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-205d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-165d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-204b0b4de00fa7…
2022-04-04 05:41 UTC2022-04N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-164b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-2074a2ff9319b5…
2019-12-13 00:20 UTC2019-12N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-1674a2ff9319b5…
2022-03-09 01:35 UTC2022-03N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-20bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-16bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-20782e0a99824c…
2021-12-28 21:50 UTC2021-12N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-16782e0a99824c…

Additional Listing Data#

Finished product
Yes
Brand name base
Advil Liquigels
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
IBUPROFEN200 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
WK2XYI10QMInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
310964Internal RxNorm lookup
731533Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
e2c09216-fd63-4d50-9878-62b36236b2e7Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
1e73f975-1ce7-705e-2bcf-788b1b5e24baProduct name520251124
16cde546-8deb-4df2-a072-dab5566ede95Product name120231003
f6d1b8d7-3bd1-4248-eddd-b60565c88015Product name420230808
874f4e63-49d2-5150-5d77-052172814ebdProduct name620230105
557673c2-8256-b351-e863-4ec71a5a64b0Product name220160714
dbc9a339-6215-4e94-9546-57a3b34902ceProduct name120160517
61c18d4e-b552-5478-8fc0-df38b93e3100Product name120140508
7b2938c9-7eb7-e312-ae90-f54f4240361eProduct name120140508
997601aa-bb5f-6971-6b90-a21132c12c7bProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
67751-148-01Advil Liquigels1 in 1 CARTONCAPSULE, LIQUID FILLED14
67751-148-01Advil Liquigels4 in 1 POUCHCAPSULE, LIQUID FILLED44
67751-148-02Advil Liquigels1 in 1 CARTONCAPSULE, LIQUID FILLED14
67751-148-03Advil Liquigels2 in 1 CARTONCAPSULE, LIQUID FILLED24

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
67751-148ADVIL LIQUIGELS (IBUPROFEN) CAPSULE, LIQUID FILLED [NAVAJO MANUFACTURING COMPANY INC.]4Current NDC, Legacy NDC, 4 package rows20230316_e2c09216-fd63-4d50-9878-62b36236b2e7.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ADVIL MIGRAINEIBUPROFENHaleon US Holdings LLCe4a6219d-4ad4-0119-4cf8-7fc39b4b59792026-07-29WarningsExact identifier
application applno (NDA): 020402
application number: NDA020402
AdvilIBUPROFENHaleon US Holdings LLC1f01c10a-9434-91a4-2ee4-352315a6b6102026-07-29WarningsExact identifier
application applno (NDA): 020402
application number: NDA020402
Advil LiquigelIBUPROFENSelect Consumer Group3ca6bc9d-090f-e412-e063-6394a90a68762026-07-03WarningsExact identifier
application applno (NDA): 020402
application number: NDA020402
Advil Liqui-GelsIBUPROFEN CAPSULE, LIQUID-FILLEDLil' Drug Store Products, Inc.c459ea1e-dabf-bba6-e053-2995a90af40f2024-12-30WarningsExact identifier
application applno (NDA): 020402
application number: NDA020402
Advil Liqui-GelsIBUPROFENLil Drug Store Products, Incba5a9a04-993e-4fd6-bb40-6edfdfb69b342024-03-27WarningsExact identifier
application applno (NDA): 020402
application number: NDA020402
Advil LiquigelsIBUPROFENNavajo Manufacturing Company Inc.e2c09216-fd63-4d50-9878-62b36236b2e72023-03-15WarningsExact identifier
application applno (NDA): 020402
application number: NDA020402
ndc (package): 67751-148-01
ndc (product): 67751-148
ndc11 (package): 67751014801

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
731533Advil 200 MG Oral CapsulePSNe2c09216-fd63-4d50-9878-62b36236b2e74
310964ibuprofen 200 MG Oral CapsulePSNe2c09216-fd63-4d50-9878-62b36236b2e74
731533ibuprofen 200 MG Oral Capsule [Advil]SBDe2c09216-fd63-4d50-9878-62b36236b2e74
310964ibuprofen 200 MG Oral CapsuleSCDe2c09216-fd63-4d50-9878-62b36236b2e74
731533Advil 200 MG Oral CapsuleSYe2c09216-fd63-4d50-9878-62b36236b2e74

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
67751-148-01677510148011 POUCH in 1 CARTON (67751-148-01) > 4 CAPSULE, LIQUID FILLED in 1 POUCH1 pouch2016-09-200000-00-00NoNoCurrent